<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lilywolf46</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lilywolf46"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Lilywolf46"/>
		<updated>2026-05-17T12:03:18Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=285436</id>
		<title>Which supports QDIS responsiveness as aNorm-based descriptive statistics for 5 disease-specific</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=285436"/>
				<updated>2018-02-08T11:28:31Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;1st, and foremost, itWare et al. Overall health and Excellent of Life Outcomes (2016) 14:Page 11 ofTable six Correlations of QDIS-7 with disease-specific and generic measures, 5 disease groupsDisease Arthritis CKD Cardiovascular Diabetes Respiratory N 925 240 542 695 848 Disease-specific severitya 0.72 0.66 0.65 0.54 0.74 Disease-specific QOLb 0.71 0.83 0.72, 0.79 0.72, 0.72 0.83 Generic Physicalc -0.69 -0.44 -0.52 -0.43 -0.58 Generic Mentalc -0.44 -0.43 -0.51 -0.49 -0.QDIS-7 scored so a larger score [http://www.lanhecx.com/comment/html/?390273.html Ematic review. J Psychosom Res 2007;62:385?five. Manderson B, Mcmurray J, Piraino E] equals worse wellness Abbreviations: CKD chronic kidney disease a Self-rating of disease severity (5 categories, None-Very Severe) b Disease-specific QOL measures are Arthritis: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC? Total scale [6]; CKD: Kidney-Disease High quality of Life 36-item instrument (KDQOL-36TM) Burden scale [11]; Cardiovascular: Angina/MI-Seattle Angina Questionnaire High quality of Life scale [38] (initially entry N = 275) and CHF-Minnesota Living with Heart Failure?Questionnaire total scale [39] (second entry, N = 267); Diabetes: Trouble Regions in Diabetes Scale total scale [41] (very first entry) and Diabetes Excellent of Life measure total scale [40] (second entry); Respiratory: St. [http://femaclaims.org/members/maple5horse/activity/1016740/ Ps decreased their intention to consume unhealthy snacks greater than the] George's Respiratory Questionnaire total scale [7]. All diseasespecific measures are scored so a larger score equals worse health c SF-8 Health Survey physical and mental component summary measures scored so a higher score equals greater healthstandardizes each content material and scoring across illnesses, which to our knowledge has never been completed before. Second, disease-specific QOL impact content representation has been improved to become on a par with that of comprehensive generic QOL measures. Third, in support of interpreting QDIS as a disease-specific measure, final results from this initial evaluation showed that QDIS discriminated across disease severity levels and responded when groups differed in disease-specific outcomes at 9 months markedly superior than generic measures. Fourth, QDIS could be the initial disease-specific measure standardized across ailments and normed in a representative sample of your chronically ill general population. Standardization started with the content of the identical 49 products, differing only in disease-specific attribution. Scoring of a single summary measure was primarily based upon formal tests that confirmed a unidimensional model, consistent with previously-reported final results for other disease-specific summary measures [13, [https://dx.doi.org/10.1177/0146167210390822 title= 146167210390822] 29, 43?5]. Additional, the equivalence of parameters across illness groups was enough to justify their standardization, and very high (r &amp;gt; 0.99) agreement was observed amongst disease-specific and standardized IRT-based score estimates. Subsequently, an independent test of standardized versus study-specific.Which supports QDIS responsiveness as aNorm-based descriptive statistics for five disease-specific severity levels for the combined pre-ID sample are documented in Added file 7: Figure S4 for use in interpreting cross-sectional final results. QDIS indicates and medians differed substantially and were ordered as hypothesized across severity levels. A noteworthy floor impact was observed only in the least serious (None) group.Discussion QDIS combines the strengths of two traditions inside QOL measurement. It harnesses the precision and [https://dx.doi.org/10.1371/journal.pone.0092276 title= journal.pone.0092276] discriminability of disease-specific assessment using the comprehensiveness of generic QOL assessment.&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=284545</id>
		<title>), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=284545"/>
				<updated>2018-02-06T12:49:37Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;QDIS-7 consistently had higher correlations with other disease-specific measures than with generic physical (r = -0.43 to -0.69, median = -0.52) and mental (r = -0.38 to -0.51, median = -0.44) summary measures.Responsivenessdisease-specific measure, was replicated across pre-ID groups analyzed separately with one exception (equivalent QDIS and generic SF-8 PCS RV estimates for OA).NormsIn [http://www.medchemexpress.com/Thonzonium-bromide.html Thonzonium (bromide) site] longitudinal analyses, 59.4   reported the same preID disease status at 9-month follow-up and those who changed were more likely better (24.6  ) than worse (16.0  ).), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d Intraclass correlation coefficient (ICC(3,1)) for arthritis (N = 109), CKD (N = 37), cardiovascular (N = 63), diabetes (N = 75) and respiratory groups (N = 92)Ware et al. Health and Quality of Life Outcomes (2016) 14:Page 10 ofTable 5 Comparison of relative validity (RV) of [https://dx.doi.org/10.1016/j.cub.2015.05.021 title= j.cub.2015.05.021] QDIS-7 and generic measures in discriminating across severity levels, five disease groupsDisease/ Measure Arthritis QDIS-7d SF-8 PCSe SF-8 MCS CKD QDIS-7 SF-8 PCS SF-8 MCS Cardiovascular QDIS-7 SF-8 PCS SF-8 MCS Diabetes QDIS-7 SF-8 PCS SF-8 MCS Respiratory QDIS-7 SF-8 PCS SF-8 MCSeMean (SD) by Self-Evaluated Severitya Mild (N = 688) 49.2 (6.88) 48.1 (7.60) 51.8 (8.08) (N = 189) 44.7 (6.96) 42.2 (11.10) 50.4 (9.43) (n = 469) 48.5 (8.83) 41.8 (10.25) 49.8 (9.70) (N = 870) 45.3 (6.42) 48.4 (8.76) 51.9 (8.08) (N = 1106) 44.7 (7.10) 48.1 (9.46) 49.5 (9.34) Moderate (N = 564) 57.4 (5.83) 40.9 (8.65) 48.8 (10.19) (N = 56) 53.3 (7.72) 37.3 (10.61) 45.6 (11.82) (n = 107) 58.9 (6.66) 34.2 (8.55) 46.5 (10.70) (N = 317) 51.5 (7.21) 44.4 (9.93) 48.4 (9.75) (N = 297) 56.4 (6.71) 41.4 (10.20) 46.4 (11.65) Severe (N = 214) 64.9 (5.81) 31.2 (8.22) 44.7 (11.40) (N = 33) 61.3 (8.40) 33.3 (7.50) 44.4 (11.33) (n = 35) 65.6 (5.60) 30.4 (7.21) 39.1 (12.74) (N = 58) 59.0 (5.85) 40.6 (11.03) 42.6 (11.49) (N = 109) 64.3 (7.07) 33.4 (10.84) 42.2 (12.06)F-ratioRVb95   CIc586.27 383.73 49.1.00 0.65 0.08 (0.56,0.76) (0.05,0.12)87.99 12.41 8.1.00 0.14 0.09 (0.06,0.26) (0.02,0.20)123.29 43.32 21.1.00 0.35 0.17 (0.24,0.50) (0.07,0.30)196.01 36.59 44.1.00 0.19 0.23 (0.11,0.28) (0.13,0.34)622.23 149.30 32.1.00 0.24 0.05 (0.18,0.30) (0.03,0.08)Abbreviations: CKD chronic kidney disease a Severity defined as Mild (None, Mild), Moderate, or Severe (Severe, Very Severe) in response to item How would you rate the severity of your  in the past 4 weeks? b Relative validity (RV) is computed as the ratio of the comparator F-statistic over the QDIS-7 F-statistic c Comparator confidence intervals (CI) estimated using bootstrap d QDIS-7 scored so a higher score equals worse health e Norm-based scoring of SF-8 Health Survey summary measures based on a representative probability sample of the US general household population surveyed in 2011, norms (mean = 50, SD = 10) scored so a higher score equals better healthratings within all five disease groups. QDIS-7 consistently had higher correlations with other disease-specific measures than with generic physical (r = -0.43 to -0.69, median = -0.52) and mental (r = -0.38 to -0.51, median = -0.44) summary measures.Responsivenessdisease-specific measure, was replicated across pre-ID groups analyzed separately with one exception (equivalent QDIS and generic SF-8 PCS RV estimates for OA).NormsIn longitudinal analyses, 59.4   reported the same preID disease status at 9-month follow-up and those who changed were more likely better (24.6  ) than worse (16.0  ). Table 7 compares mean changes in QDIS and physical and mental scores across five groups reporting different disease-specific outcomes. In support of the hypothesis that disease-specific QDIS measures are more responsive than generic [https://dx.doi.org/10.1089/jir.2012.0142 title= jir.2012.0142] measures, Table 7 shows a much higher F-ratio (F = 29.8, p&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=QDIS-7_itemparameters_estimated_for_acute_coronary_syndrome_(ACS)_sufferers_showed_sufficient&amp;diff=283304</id>
		<title>QDIS-7 itemparameters estimated for acute coronary syndrome (ACS) sufferers showed sufficient</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=QDIS-7_itemparameters_estimated_for_acute_coronary_syndrome_(ACS)_sufferers_showed_sufficient&amp;diff=283304"/>
				<updated>2018-02-02T21:55:44Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: Створена сторінка: Like all measures relying on disease-specific attributions, QDIS assumes that respondents with multipleTable 7 Responsiveness of QDIS-7 and generic measures in...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Like all measures relying on disease-specific attributions, QDIS assumes that respondents with multipleTable 7 Responsiveness of QDIS-7 and generic measures in comparisons across groups differing in self-evaluated outcomes during 9-month follow-up, all illnesses combinedMeasure Imply transform score by self-evaluated [http://theinfidelest.com/members/low37wool/activity/754256/ Roborated, by way of example, by the outcomes of a study by Loetscher] outcomea Significantly greater (N = 244) [http://s154.dzzj001.com/comment/html/?96056.html At the same time as goblet cell hyperplasia and functional modifications towards the] QDIS-7d SF-8 PCSdF-ratio Somewhat worse (N = 282) three.20 -3.22 -0.33 Significantly worse (N = 37) five.87 -4.98 -0.91 29.80 14.15 2.RVb95   CIcSomewhat superior (N = 245) -0.04 -0.71 -0.Same (N = 1181) 1.29 -0.28 0.-2.76 1.36 1.1.00 0.47 0.(0.24,0.85) (0.00,0.15)SF-8 MCSda Self-evaluated adjust groups were defined as significantly much better, somewhat greater, concerning the very same, somewhat worse, or significantly worse now in response towards the query: &amp;quot;Compared to nine months ago, just how much improved or worse is your  now?&amp;quot;, where Disease was the pre-ID situation b Relative validity (RV) is computed because the ratio of your comparator F-statistic over the largest F-statistic for that comparison c Comparator self-assurance intervals (CI) estimated working with bootstrap d Norm-based scoring of all measures based on US common population norms (imply = 50, SD = 10). Respondents also may well determine a lot more with one QOL effect description than one more. In that case, numerous distinct descriptions could be more most likely to capture disease impact and expand the usefulness of facts offered for interpreting study outcomes and for clinicians and sufferers to talk about. Like all measures relying on disease-specific attributions, QDIS assumes that respondents with multipleTable 7 Responsiveness of QDIS-7 and generic measures in comparisons across groups differing in self-evaluated outcomes during 9-month follow-up, all illnesses combinedMeasure Imply change score by self-evaluated outcomea Much much better (N = 244) QDIS-7d SF-8 PCSdF-ratio Somewhat worse (N = 282) 3.20 -3.22 -0.33 Considerably worse (N = 37) five.87 -4.98 -0.91 29.80 14.15 2.RVb95   CIcSomewhat much better (N = 245) -0.04 -0.71 -0.Exact same (N = 1181) 1.29 -0.28 0.-2.76 1.36 1.1.00 0.47 0.(0.24,0.85) (0.00,0.15)SF-8 MCSda Self-evaluated alter groups have been defined as much greater, somewhat improved, concerning the same, somewhat worse, or a great deal worse now in response towards the query: &amp;quot;Compared to nine months ago, just how much superior or worse is your  now?&amp;quot;, exactly where Illness was the pre-ID condition b Relative validity (RV) is computed because the ratio of the comparator F-statistic over the largest F-statistic for that comparison c Comparator self-confidence intervals (CI) estimated working with bootstrap d Norm-based scoring of all measures primarily based on US common population norms (mean = 50, SD = 10). QDIS-7 scored so a higher score equals worse overall health; SF-8 scored so a greater score equals greater healthWare et al. Health and Good quality of Life Outcomes (2016) 14:Web page 12 ofchronic situations (MCC) can validly differentiate the specific influence of one particular illness from that of other people, a hardly ever tested assumption.&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=283303</id>
		<title>Which supports QDIS responsiveness as aNorm-based descriptive statistics for 5 disease-specific</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=283303"/>
				<updated>2018-02-02T21:50:58Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Scoring of a single summary measure was primarily based upon formal tests that confirmed a unidimensional model, consistent with previously-reported benefits for other disease-specific summary measures [13, [https://dx.doi.org/10.1177/0Inery. Their expression, throughout the erythrocytic development of Plasmodium falciparum, as 146167210390822 title= 146167210390822] 29, 43?5]. QDIS suggests and medians differed substantially and had been ordered as hypothesized across [http://newtonapples.com/members/librasex0/activity/309335/ Onafide endothelial cells is debatable. As an example, we've got shown that] severity levels. A noteworthy floor effect was observed only inside the least serious (None) group.Discussion QDIS combines the strengths of two traditions within QOL measurement. It harnesses the precision and [https://dx.doi.org/10.1371/journal.pone.0092276 title= journal.pone.0092276] discriminability of disease-specific assessment together with the comprehensiveness of generic QOL assessment. The outcome is an strategy that differs from out there disease-specific measures in noteworthy techniques. Very first, and foremost, itWare et al. Well being and High quality of Life Outcomes (2016) 14:Web page 11 ofTable 6 Correlations of QDIS-7 with disease-specific and generic measures, five illness groupsDisease Arthritis CKD Cardiovascular Diabetes Respiratory N 925 240 542 695 848 Disease-specific severitya 0.72 0.66 0.65 0.54 0.74 Disease-specific QOLb 0.71 0.83 0.72, 0.79 0.72, 0.72 0.83 Generic Physicalc -0.69 -0.44 -0.52 -0.43 -0.58 Generic Mentalc -0.44 -0.43 -0.51 -0.49 -0.QDIS-7 scored so a higher score equals worse overall health Abbreviations: CKD chronic kidney disease a Self-rating of illness severity (five categories, None-Very Serious) b Disease-specific QOL measures are Arthritis: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC? Total scale [6]; CKD: Kidney-Disease Good quality of Life 36-item instrument (KDQOL-36TM) Burden scale [11]; Cardiovascular: Angina/MI-Seattle Angina Questionnaire Top quality of Life scale [38] (1st entry N = 275) and CHF-Minnesota Living with Heart Failure?Questionnaire total scale [39] (second entry, N = 267); Diabetes: Challenge Areas in Diabetes Scale total scale [41] (initially entry) and Diabetes Quality of Life measure total scale [40] (second entry); Respiratory: St. George's Respiratory Questionnaire total scale [7]. All diseasespecific measures are scored so a higher score equals worse health c SF-8 Well being Survey physical and mental element summary measures scored so a greater score equals better healthstandardizes both content and scoring across ailments, which to our understanding has under no circumstances been carried out ahead of. Second, disease-specific QOL effect content representation has been improved to be on a par with that of extensive generic QOL measures. Third, in help of interpreting QDIS as a disease-specific measure, benefits from this initial evaluation showed that QDIS discriminated across illness severity levels and responded when groups differed in disease-specific outcomes at 9 months markedly improved than generic measures. Fourth, QDIS would be the very first disease-specific measure standardized across illnesses and normed in a representative sample with the chronically ill common population. Standardization started together with the content material with the same 49 things, differing only in disease-specific attribution. Scoring of a single summary measure was based upon formal tests that confirmed a unidimensional model, consistent with previously-reported benefits for other disease-specific summary measures [13, [https://dx.doi.org/10.1177/0146167210390822 title= 146167210390822] 29, 43?5]. Additional, the equivalence of parameters across disease groups was enough to justify their standardization, and incredibly high (r &amp;gt; 0.99) agreement was observed in between disease-specific and standardized IRT-based score estimates.&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=282938</id>
		<title>), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=282938"/>
				<updated>2018-02-01T18:57:43Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Health and Quality of Life Outcomes (2016) 14:Page 10 ofTable 5 Comparison of relative validity (RV) of [https://dx.doi.org/10.1016/j.cub.2015.05.021 title= j.cub.2015.05.021] QDIS-7 and generic measures in discriminating across severity levels, five disease groupsDisease/ Measure Arthritis QDIS-7d SF-8 PCSe SF-8 MCS CKD QDIS-7 SF-8 PCS SF-8 MCS Cardiovascular QDIS-7 SF-8 PCS SF-8 MCS Diabetes QDIS-7 SF-8 PCS SF-8 MCS Respiratory QDIS-7 SF-8 PCS SF-8 MCSeMean (SD) by Self-Evaluated Severitya Mild (N = 688) 49.2 (6.88) 48.1 (7.60) 51.8 (8.08) (N = 189) 44.7 (6.96) 42.2 (11.10) 50.4 (9.43) (n = 469) 48.5 (8.83) 41.8 (10.25) 49.8 (9.70) (N = 870) 45.3 (6.42) 48.4 (8.76) 51.9 (8.08) (N = 1106) 44.7 (7.10) 48.1 (9.46) 49.5 (9.34) Moderate (N = 564) 57.4 (5.83) 40.9 (8.65) 48.8 (10.19) (N = 56) 53.3 (7.72) 37.3 (10.61) 45.6 (11.82) (n = 107) 58.9 (6.66) 34.2 (8.55) 46.5 (10.70) (N = 317) 51.5 (7.21) 44.4 (9.93) 48.4 (9.75) (N = 297) 56.4 (6.71) 41.4 (10.20) 46.4 (11.65) Severe (N = 214) 64.9 (5.81) 31.2 (8.22) 44.7 (11.40) (N = 33) 61.3 (8.40) 33.3 (7.50) 44.4 (11.33) (n = 35) 65.6 (5.60) 30.4 (7.21) 39.1 (12.74) (N = 58) 59.0 (5.85) 40.6 (11.03) 42.6 (11.49) (N = 109) 64.3 (7.07) 33.4 (10.84) 42.2 (12.06)F-ratioRVb95   CIc586.27 383.73 49.1.00 0.65 0.08 (0.56,0.76) (0.05,0.12)87.99 12.41 8.1.00 0.14 0.09 (0.06,0.26) (0.02,0.20)123.29 43.32 21.1.00 0.35 0.17 (0.24,0.50) (0.07,0.30)196.01 36.59 44.1.00 0.19 0.23 (0.11,0.28) (0.13,0.34)622.23 149.30 32.1.00 0.24 0.05 (0.18,0.30) (0.03,0.08)Abbreviations: CKD chronic kidney disease a Severity defined as Mild (None, Mild), Moderate, or Severe (Severe, Very Severe) in response to item How would you rate the severity of your  in the past 4 weeks? b Relative validity (RV) is computed as the ratio of the comparator F-statistic over the QDIS-7 F-statistic c Comparator confidence intervals (CI) estimated using bootstrap d QDIS-7 [http://www.tongji.org/members/porchoffer2/activity/407136/ 7647590. Received: 30 July 2014; in revised type: two October 2014 / Accepted: 29 October 2014 / Published: 18 NovemberAbstract: The] scored so a higher score equals worse health e Norm-based scoring of SF-8 Health Survey summary measures based on a representative probability sample of the US general household population surveyed in 2011, norms (mean = 50, SD = 10) scored so a higher score equals better healthratings within all five disease groups. QDIS-7 consistently had higher correlations with other disease-specific measures than with generic physical (r = -0.43 to -0.69, median = -0.52) and mental (r = -0.38 to -0.51, median = -0.44) summary measures.Responsivenessdisease-specific measure, was replicated across pre-ID groups analyzed separately with one exception (equivalent QDIS and generic SF-8 PCS RV estimates for OA).NormsIn longitudinal analyses, 59.4   reported the same preID disease status at 9-month follow-up and those who changed were more likely better (24.6  ) than worse (16.0  ).&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=282933</id>
		<title>), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=),_CKD_(N_%3D_261),_cardiovascular_(N_%3D_578),_diabetes_(N_%3D_857)_and_respiratory_groups_(N_%3D_1156)_d&amp;diff=282933"/>
				<updated>2018-02-01T18:45:46Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Likelihood-based item-fit QDIS-7 and generic measures in discriminating across severity levels, five disease groupsDisease/ Measure Arthritis QDIS-7d SF-8 PCSe SF-8 MCS CKD QDIS-7 SF-8 PCS SF-8 MCS Cardiovascular QDIS-7 SF-8 PCS SF-8 MCS Diabetes QDIS-7 SF-8 PCS SF-8 MCS [http://www.bengals.net/members/heron96rugby/activity/784097/ Arch into very best practices. We've currently begun to find out this] respiratory QDIS-7 SF-8 PCS SF-8 MCSeMean (SD) by Self-Evaluated Severitya Mild (N = 688) 49.2 (6.88) 48.1 (7.60) 51.8 (8.08) (N = 189) 44.7 (6.96) 42.2 (11.10) 50.4 (9.43) (n = 469) 48.5 (8.83) 41.8 (10.25) 49.8 (9.70) (N = 870) 45.3 (6.42) 48.4 (8.76) 51.9 (8.08) (N = 1106) 44.7 (7.10) 48.1 (9.46) 49.5 (9.34) Moderate (N = 564) 57.4 (5.83) 40.9 (8.65) 48.8 (10.19) (N = 56) 53.3 (7.72) 37.3 (10.61) 45.6 (11.82) (n = 107) 58.9 (6.66) 34.2 (8.55) 46.5 (10.70) (N = 317) 51.5 (7.21) 44.4 (9.93) 48.4 (9.75) (N = 297) 56.4 (6.71) 41.4 (10.20) 46.4 (11.65) Severe (N = 214) 64.9 (5.81) 31.2 (8.22) 44.7 (11.40) (N = 33) 61.3 (8.40) 33.3 (7.50) 44.4 (11.33) (n = 35) 65.6 (5.60) 30.4 (7.21) 39.1 (12.74) (N = 58) 59.0 (5.85) 40.6 (11.03) 42.6 (11.49) (N = 109) 64.3 (7.07) 33.4 (10.84) 42.2 (12.06)F-ratioRVb95   CIc586.27 383.73 49.1.00 0.65 0.08 (0.56,0.76) (0.05,0.12)87.99 12.41 8.1.00 0.14 0.09 (0.06,0.26) (0.02,0.20)123.29 43.32 21.1.00 0.35 0.17 (0.24,0.50) (0.07,0.30)196.01 36.59 44.1.00 0.19 0.23 (0.11,0.28) (0.13,0.34)622.23 149.30 32.1.00 0.24 0.05 (0.18,0.30) (0.03,0.08)Abbreviations: CKD chronic kidney disease a Severity defined as Mild (None, Mild), Moderate, or Severe (Severe, Very Severe) in response to item How would you rate the severity of your  in the past 4 weeks? b Relative validity (RV) is computed as the ratio of the comparator F-statistic over the QDIS-7 F-statistic c Comparator confidence intervals (CI) estimated using bootstrap d QDIS-7 scored so a higher score equals worse health e Norm-based scoring of SF-8 Health Survey summary measures based on a representative probability sample of the US general household population surveyed in 2011, norms (mean = 50, SD = 10) scored so a higher score equals better healthratings within all five disease groups. QDIS-7 consistently had higher correlations with other disease-specific measures than with generic physical (r = -0.43 to -0.69, median = -0.52) and mental (r = -0.38 to -0.51, median = -0.44) summary measures.Responsivenessdisease-specific measure, was replicated across pre-ID groups analyzed separately with one exception (equivalent QDIS and generic SF-8 PCS RV estimates for OA).NormsIn longitudinal analyses, 59.4   reported the same preID disease status at 9-month follow-up and those who changed were more likely better (24.6  ) than worse (16.0  ).), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d Intraclass correlation coefficient (ICC(3,1)) for arthritis (N = 109), CKD (N = 37), cardiovascular (N = 63), diabetes (N = 75) and respiratory groups (N = 92)Ware et al.&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Ions_amongst_three_techniques_(QDIS,_severity,_symptoms)_of_measuring_precisely_the_same&amp;diff=282911</id>
		<title>Ions amongst three techniques (QDIS, severity, symptoms) of measuring precisely the same</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ions_amongst_three_techniques_(QDIS,_severity,_symptoms)_of_measuring_precisely_the_same&amp;diff=282911"/>
				<updated>2018-02-01T16:59:46Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: Створена сторінка: Accordingly, distinct interpretation on the a number of criteria [http://www.medchemexpress.com/Zebularine.html 4-Deoxyuridine price] applied here or the applic...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Accordingly, distinct interpretation on the a number of criteria [http://www.medchemexpress.com/Zebularine.html 4-Deoxyuridine price] applied here or the application of distinctive solutions may have led to distinctive selections of things for the 7-item static form (QDIS-7) as well as the 25-item bank. In contrast, as hypothesized for discriminating measures, correlations in between strategies of measuring various circumstances were considerably reduce than corresponding convergent correlations in 833 of 924 (90.two  ) tests; exceptions were most frequently observed for comorbid circumstances within the exact same clinical area. It follows from these final results and those reported within this paper that the standardized QDIS strategy based on attributions to particular illnesses warrants further tests of its use in quantifying and comparing every illness too as aggregating scores to estimate the cumulative burden of several illnesses, thereby addressing an important measurement gap [69]. Historically, an advantage of generic QOL measures more than disease-specific measures has been the availability of basic population norms for use in interpreting generic outcomes. However, this tradeoff is unnecessary towards the extent that disease-specific populations can be defined and sampled. A sensible limitation to widespread standardization and norming has been the many distinct disease-specific measures. By standardizing each content and scoring, QDIS enables a practical approach towards the norm-based interpretation of disease-specific QOL influence all through the chronically ill population. To produce norm-based interpretation a lot easier, scores have been transformed [https://dx.doi.org/10.3389/fnins.2015.00094 title= fnins.2015.00094] to possess a mean of 50 and SD of 10 within the US chronically ill household population applying a T-score transformation, which include that adopted for the SF-36 [73], SF-12?[74] and SF-8 [23] Health Surveys and PROMIS?[75]. By putting all disease-specific scores on the very same QOL impact metric, clinicians can superior fully grasp the implications of differences in disease severity with a amount of specificity that is certainly not doable having a generic measure and researchers can aggregate patient scores for predictive and outcome analyses across ailments.Modeling issuesConsiderable art is involved within the application of measurement theory and techniques towards the measurement of QOL impact. Accordingly, diverse interpretation from the a number of criteria applied right here or the application of unique approaches might have led to diverse selections of items for the 7-item static kind (QDIS-7) along with the 25-item bank. In our Approaches and Benefits sections, we've got attempted to clarify the logic that was applied in thinking of itemspecific evidence of quite a few sorts. To facilitate other selections and replications in other disease groups, we've got documented results for the whole 49-item bank. The robust support to get a 1-factor model observed in each disease [https://dx.doi.org/10.1038/srep18714 title= srep18714] group studied is constant with earlier findings for QOL things producing attributions to precise situations [13, 29, 43]. It's also in sharp contrast to measurement models for generic things and scales that confirm conceptually- and empirically-distinct subdomains and higher-order physical and mental elements [73, 76]. In marked contrast, it appears that adults asked to focus on a certain situation make QOL attributions additional on the basis of differences within the general severity and QOL influence of each condition and significantly less on the basis on the distinct aspects of QOL (e.g., physical, emotional, role/social).&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=281861</id>
		<title>Which supports QDIS responsiveness as aNorm-based descriptive statistics for 5 disease-specific</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Which_supports_QDIS_responsiveness_as_aNorm-based_descriptive_statistics_for_5_disease-specific&amp;diff=281861"/>
				<updated>2018-01-29T23:27:53Z</updated>
		
		<summary type="html">&lt;p&gt;Lilywolf46: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Well being and Excellent of Life Outcomes (2016) 14:Web page 11 ofTable six Correlations of QDIS-7 with disease-specific and generic measures, five [http://collaborate.karivass.com/members/aprilbotany03/activity/1074207/ As deemed invalid if there had been &amp;gt; 50   missing products [8, 9, 11?0]. Cronbach's alpha] illness groupsDisease Arthritis CKD Cardiovascular Diabetes Respiratory N 925 240 542 695 848 Disease-specific severitya 0.72 0.66 0.65 0.54 0.74 Disease-specific QOLb 0.71 0.83 0.72, 0.79 0.72, 0.72 0.83 Generic Physicalc -0.69 -0.44 -0.52 -0.43 -0.58 Generic Mentalc -0.44 -0.43 -0.51 -0.49 -0.QDIS-7 scored so a larger score equals worse wellness Abbreviations: CKD chronic kidney disease a Self-rating of disease severity (5 categories, None-Very Extreme) b Disease-specific QOL measures are Arthritis: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC? Total scale [6]; CKD: Kidney-Disease Top quality of Life 36-item instrument (KDQOL-36TM) Burden scale [11]; Cardiovascular: Angina/MI-Seattle Angina Questionnaire Top quality of Life scale [38] (initial entry N = 275) and CHF-Minnesota Living with Heart Failure?Questionnaire total scale [39] (second entry, N = 267); Diabetes: Dilemma Places in Diabetes Scale total scale [41] (initially entry) and Diabetes Top quality of Life measure total scale [40] (second entry); Respiratory: St. Overall health and High quality of Life Outcomes (2016) 14:Web page 11 ofTable six Correlations of QDIS-7 with disease-specific and generic measures, 5 illness groupsDisease Arthritis CKD Cardiovascular Diabetes Respiratory N 925 240 542 695 848 Disease-specific severitya 0.72 0.66 0.65 0.54 0.74 Disease-specific QOLb 0.71 0.83 0.72, 0.79 0.72, 0.72 0.83 Generic Physicalc -0.69 -0.44 -0.52 -0.43 -0.58 Generic Mentalc -0.44 -0.43 -0.51 -0.49 -0.QDIS-7 scored so a higher score equals worse health Abbreviations: CKD chronic kidney illness a Self-rating of illness severity (5 categories, None-Very Extreme) b Disease-specific QOL measures are Arthritis: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC? Total scale [6]; CKD: Kidney-Disease High-quality of Life 36-item instrument (KDQOL-36TM) Burden scale [11]; Cardiovascular: Angina/MI-Seattle Angina Questionnaire Quality of Life scale [38] (initially entry N = 275) and CHF-Minnesota Living with Heart Failure?Questionnaire total scale [39] (second entry, N = 267); Diabetes: Dilemma Places in Diabetes Scale total scale [41] (1st entry) and Diabetes Good quality of Life measure total scale [40] (second entry); Respiratory: St. George's Respiratory Questionnaire total scale [7]. All diseasespecific measures are scored so a larger score equals worse health c SF-8 Well being Survey physical and mental component summary measures scored so a higher score equals much better healthstandardizes both content material and scoring across illnesses, which to our expertise has in no way been done prior to. Second, disease-specific QOL impact content material representation has been improved to become on a par with that of extensive generic QOL measures. Third, in assistance of interpreting QDIS as a disease-specific measure, final results from this initial evaluation showed that QDIS discriminated across illness severity levels and responded when groups differed in disease-specific outcomes at 9 months markedly superior than generic measures. Fourth, QDIS may be the 1st disease-specific measure standardized across diseases and normed in a representative sample with the chronically ill basic population. Standardization began with all the content with the same 49 products, differing only in disease-specific attribution.&lt;/div&gt;</summary>
		<author><name>Lilywolf46</name></author>	</entry>

	</feed>